BIO-TECHNE Corp — Director's Dealing 2019

May 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-05-01

Reporting Person: Kelderman Kim (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-01	Common Stock	M	1667.00	$202.13	Acquired	1667.00	Direct
2019-05-01	Common Stock	F	844.00	$202.13	Disposed	823.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-01	Restricted Stock	$0.00	M	1667.00	Disposed	2025-05-01	Common Stock (1667.00)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$	2025-05-01	Common Stock (3333.00)	3333.00	Direct
Restricted Stock Units	$		Common Stock (1691.00)	1691.00	Direct
Stock Options (Right to buy)	$177.32	2025-08-08	Common Stock (12044.00)	12044.00	Direct
Stock Options (Right to buy)	$177.32	2025-08-08	Common Stock (9033.00)	9033.00	Direct
Stock Options (Right to buy)	$150.78	2025-05-01	Common Stock (2652.00)	2652.00	Direct
Stock Options (Right to buy)	$150.78	2025-05-01	Common Stock (7348.00)	7348.00	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: Vests 1,666 shares each on 5/1/2020 and 1,667 shares on 5/1/2021

F3: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F4: 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022

F5: 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022

F6: 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022